10X Genomics Inc (TXG NASDAQ) stock market data APIs
$12.7505
-0.44(-3.5%)
as of July 11, 2025
Try our APIs with
free plan!
10X Genomics Inc Financial Data Overview
Price chart is built with
Anychart
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Prev. Close
12.7505
Open
12.3074
High
12.9227
Low
12.2624
52 wk Range
6.78-24.76
Market Cap
1 576 M
Shares Outstanding
111 M
Revenue
625 M
EPS
-0.1018
Beta
1.981
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get 10X Genomics Inc data using free add-ons & libraries
Get 10X Genomics Inc Fundamental Data
10X Genomics Inc Fundamental data includes:
- Net Revenue: 625 M
- EBITDA: -146 882 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-28
- EPS/Forecast: -0.29
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
10X Genomics Inc News
New
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market se...
Canaccord Genuity reiterates Buy rating on 10X Genomics stock at $15
Investing.com - Canaccord Genuity has reiterated its Buy rating and $15.00 price target on 10X Genomics (NASDAQ:TXG), citing the company’s potential to benefit from large-scale single cell studies a...
3 Healthcare Stocks Skating on Thin Ice
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COV...
RBC says it is seeing "healthy" investor interest in gold stocks
Investing.com - Investor interest in gold equities remains "healthy and growing," but is not becoming "overheated," according to analysts at RBC Capital Markets. In a note to clients, the brokerage ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
